Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple Myeloma
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Patient & Survivor CareCOVID-19 UpdatesMixed TopicsMultiple Myeloma
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareMultiple Myeloma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Steroid complications in GVHD common, boost costs of careFebruary 19, 2021TransplantALLMultiple MyelomaDLBCLB Cell Lymphoma
Chronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021TransplantMyelodysplastic SyndromeMultiple MyelomaALLAMLDLBCLB Cell Lymphoma
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplantDecember 18, 2020Multiple MyelomaTransplant
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myelomaDecember 15, 2020Multiple Myeloma
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesTransplantMultiple MyelomaMyelodysplastic Syndrome
